Daxor Cash on Hand 2012-2011 | DXR

Daxor cash on hand from 2012 to 2011. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Daxor Annual Cash on Hand
(Millions of US $)
2011 $56
Daxor Quarterly Cash on Hand
(Millions of US $)
2011-12-31 $56
2011-09-30 $52
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.065B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.581B 13.26
Quest Diagnostics (DGX) United States $27.271B 23.22
DaVita (DVA) United States $12.179B 14.91
Encompass Health (EHC) United States $12.036B 20.89
Elanco Animal Health (ELAN) United States $11.491B 21.70
Chemed (CHE) United States $6.620B 23.60
RadNet (RDNT) United States $6.069B 175.27
LifeStance Health (LFST) United States $4.991B 100.46
Option Care Health (OPCH) United States $3.523B 14.89
Aveanna Healthcare Holdings (AVAH) United States $3.123B 21.68
Addus HomeCare (ADUS) United States $2.164B 19.57
Astrana Health (ASTH) United States $2.138B 22.69
Pennant (PNTG) United States $1.396B 36.34
U.S Physical Therapy (USPH) United States $1.220B 32.19
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Psychemedics (PMD) United States $0.000B 0.00